PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcmicrBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Microbiology
 
BMC Microbiol. 2010; 10: 225.
Published online Aug 25, 2010. doi:  10.1186/1471-2180-10-225
PMCID: PMC2941501
The liposoluble proteome of Mycoplasma agalactiae: an insight into the minimal protein complement of a bacterial membrane
Carla Cacciotto,#1 Maria Filippa Addis,#1,2 Daniela Pagnozzi,2 Bernardo Chessa,1 Elisabetta Coradduzza,1 Laura Carcangiu,1 Sergio Uzzau,2,3 Alberto Alberti,corresponding author#1 and Marco Pittau#1
1Dipartimento di Patologia e Clinica Veterinaria, Università degli Studi di Sassari, Sassari, Italy
2Porto Conte Ricerche Srl, Tramariglio, Alghero (SS), Italy
3Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy
corresponding authorCorresponding author.
#Contributed equally.
Carla Cacciotto: ccacciotto/at/uniss.it; Maria Filippa Addis: addis/at/portocontericerche.it; Daniela Pagnozzi: pagnozzi/at/portocontericerche.it; Bernardo Chessa: bchessa/at/uniss.it; Elisabetta Coradduzza: ecoradduzza/at/uniss.it; Laura Carcangiu: lcarcangiu/at/uniss.it; Sergio Uzzau: uzzau/at/portocontericerche.it; Alberto Alberti: calberti/at/uniss.it; Marco Pittau: pittau/at/uniss.it
Received May 4, 2010; Accepted August 25, 2010.
Background
Mycoplasmas are the simplest bacteria capable of autonomous replication. Their evolution proceeded from gram-positive bacteria, with the loss of many biosynthetic pathways and of the cell wall. In this work, the liposoluble protein complement of Mycoplasma agalactiae, a minimal bacterial pathogen causing mastitis, polyarthritis, keratoconjunctivitis, and abortion in small ruminants, was subjected to systematic characterization in order to gain insights into its membrane proteome composition.
Results
The selective enrichment for M. agalactiae PG2T liposoluble proteins was accomplished by means of Triton X-114 fractionation. Liposoluble proteins were subjected to 2-D PAGE-MS, leading to the identification of 40 unique proteins and to the generation of a reference 2D map of the M. agalactiae liposoluble proteome. Liposoluble proteins from the type strain PG2 and two field isolates were then compared by means of 2D DIGE, revealing reproducible differences in protein expression among isolates. An in-depth analysis was then performed by GeLC-MS/MS in order to achieve a higher coverage of the liposoluble proteome. Using this approach, a total of 194 unique proteins were identified, corresponding to 26% of all M. agalactiae PG2T genes. A gene ontology analysis and classification for localization and function was also carried out on all protein identifications. Interestingly, the 11.5% of expressed membrane proteins derived from putative horizontal gene transfer events.
Conclusions
This study led to the in-depth systematic characterization of the M. agalactiae liposoluble protein component, providing useful insights into its membrane organization.
Mycoplasmas are the smallest and simplest prokaryotes capable of self-replication, being provided only with the minimal machinery required for survival. During evolution, they have regressively evolved from gram-positive bacteria by reduction of their genome to an essential minimum, economizing their structural elements, metabolic pathways, and genetic resources [1].
Among other consequences, this cost-cutting strategy led to loss of the cell-wall component, and therefore to lack of a peptidoglycan "shell". Instead, sterols are incorporated into the lipid bilayer, providing resistance to rupture, but still allowing a certain flexibility of cell shape. Integral and associated membrane proteins are therefore directly exposed and act as the immediate bacterial interface, playing a major role in survival and pathogenesis [2,3]. Gathering information on membrane proteins of such a pathogen might provide novel and interesting insights on its biology, and generate useful information for improving diagnosis, vaccination, and therapy. Recently, a large-scale study was carried out on the proteome of the human pathogen Mycoplasma penetrans, based on the TAP-MS approach [4]. However, membrane proteins were not included in this study, since they require dedicated protocols for purification and analysis and present numerous challenges.
Many members of the genus Mycoplasma are pathogenic for humans, animals, plants, and insects. M. agalactiae is the etiological agent of Contagious Agalactia (CA), a serious disease of sheep and goats characterized by mastitis, polyarthritis, keratoconjunctivitis, and abortion [1,5,6]. CA has a worldwide distribution and is endemic in Mediterranean Countries [7], causing severe economic losses in areas where economy is largely based on small ruminant milk production [5].
In Europe, the disease has been tentatively controlled either by vaccination or with serological tools based on recombinant surface proteins [8-13]. At present, the two above mentioned strategies are not actually compatible until proper DIVA (Differentiating Infected from Vaccinated Animals) vaccines will allow discrimination of vaccinated animals from naturally infected ones. The highly immunogenic, surface-associated membrane proteins represent key antigens for diagnosis and vaccine development. However, the finding of constantly expressed surface proteins in mycoplasmas is complicated by the existence of mechanisms aimed to evade the host immune response [1,14-17]. Surface-associated proteins are also pivotal for pathogenesis by acting as cytoadhesins [18]. To date, a limited number of constantly expressed surface proteins have been described in M. agalactiae. Among them, P30, P48, and P80 were described as antigens [19-21]; other proteins belong to the variable surface membrane proteins family (Vpma) [14,17], and P40 was suggested to play an important role in attachment to the host cell [18].
Genetic approaches traditionally used for large scale investigation of protein sets have been poorly applied to mycoplasmas. The expression of immunogenic Mycoplasma proteins in Escherichia coli expression libraries is hampered by the very high A+T content (almost 80%) and by the Mycoplasma-specific codon usage, resulting in abnormal internal transcription/translation and in premature termination, respectively [22,23]. In 2007, the full genome sequence of the M. agalactiae type strain PG2 (PG2T) was published [24] and paved the way for systematic proteomic studies in mycoplasmas.
The combination of 2-D PAGE and mass spectrometry (MS) is a well-established method for the systematic and comparative study of proteomes, since it allows the simultaneous visualization and identification of the protein complement of a cell. However, it is commonly reported that standard 2-D PAGE lacks in resolution of very hydrophobic and basic proteins, which are particularly abundant in the Mycoplasma membrane [25-27]. Indeed, membrane proteins are poorly detected in 2-D PAGE maps of Mycoplasma total protein extracts [22,28]. Triton X-114 fractionation may assist in solving this problem, since it was demonstrated to enable a selective enrichment in hydrophobic proteins [29,30]. Triton X-114 fractionation followed by 2-D PAGE remains the method of choice for proteomic characterization of the membrane protein subset [31], and for differential analysis of membrane protein expression among bacterial strains [32]. More specifically, the recently developed Differential In Gel Electrophoresis (DIGE) [33-35], based on labeling of protein samples with fluorescent dyes before 2-D electrophoresis, enables the accurate analysis of differences in protein abundance between samples. However, considering the above mentioned intrinsic limitations of 2-D PAGE, other gel-based proteomic approaches, such as one-dimensional PAGE and Liquid Chromatography-Tandem Mass Spectrometry (GeLC-MS/MS) [36], can be combined with the 2-D PAGE/MS in order to mine deeper into a liposoluble proteome.
In this study, the membrane proteome of M. agalactiae was characterized by means of Triton X-114 fractionation, 2-D PAGE-MS, GeLC-MS/MS, and Gene Ontology classification. Differential expression of membrane proteins among M. agalactiae strains was also evaluated by 2D DIGE.
Extraction of bacterial proteins and isolation of liposoluble proteins
This study was aimed to the systematic characterization of M. agalactiae PG2T membrane proteins by means of a gel-based proteomic approach. In order to increase coverage for liposoluble proteins, a commercial fractionation method and the classical Triton X-114 fractionation protocol were applied to M. agalactiae PG2T cell lysates. The best results were obtained by means of Triton X-114 fractionation. Figure Figure1A1A illustrates the hydrosoluble and liposoluble fractions obtained from M. agalactiae PG2T, flanked by the total protein pattern for comparison. The efficiency of the procedure in separating liposoluble proteins was evaluated by Western immunoblotting using a rabbit hyperimmune serum raised against M. agalactiae P48, a previously characterized surface lipoprotein [12,19]. As expected, presence of P48 was observed only in the total extract and in the Triton X-114 phase (Figure (Figure1B),1B), confirming that the fractionation method enabled separation and enrichment of hydrophobic proteins.
Figure 1
Figure 1
Total protein patterns and Western immunoblotting reactivity of M. agalactiae PG2T proteins. Panel A. Coomassie blue staining. Panel B: Immunoblotting reactivity obtained with antibodies against the P48 lipoprotein. From left to right: M: molecular weight (more ...)
2-D PAGE/MS of M. agalactiae PG2T liposoluble proteins
Total proteins and the Triton X-114 soluble fraction of M. agalactiae PG2T were subjected to 2-D PAGE separation in order to evaluate the extent of enrichment in basic and liposoluble proteins. As illustrated in Figure Figure2,2, left panel, a very high number of spots were present in the total protein map of M. agalactiae PG2T but, as expected, basic proteins were poorly represented. Upon comparison, the 2-D PAGE map generated with the Triton X-114 soluble fraction showed a significant enrichment in basic proteins, with an excellent resolution also in high-abundance spots (Figure (Figure2,2, right panel).
Figure 2
Figure 2
2-D PAGE patterns of M. agalactiae PG2T protein extracts. Left: 2-D PAGE of a M. agalactiae PG2T total protein extract. Right: 2-D PAGE of M. agalactiae PG2T liposoluble proteins obtained after Triton X-114 fractionation.
In order to attain a systematic characterization of the liposoluble proteome, the Triton X-114 phase fraction of M. agalactiae PG2T was subjected to 2-D PAGE under three different pI intervals: 3-10NL, 7-11, and 4-7 (Additional files 1, 2, and 3). From these 2D maps, about 300 spots were excised and identified by MALDI-TOF and nanoHPLC-nanoESI-Q-TOF MS. This approach led to the successful identification of 40 unique proteins, corresponding to 5.4% of all M. agalactiae PG2T genes. Figure Figure33 reports a representative liposoluble protein map summarizing the main protein identifications accomplished on 2-D spots. A detailed description of all protein identifications is given in Additional file 4. Experimentally deduced molecular weight and pI of protein spots were compared with the theoretical parameters obtained from MASCOT, and most experimental data were in accordance with theoretical data. Few proteins, such as VpmA, were detected in multiple spots at different pIs and molecular weights, as expected for this class of lipoproteins which undergo size variation. The well-known immunogenic proteins [12,17,19-21] were all detected by 2-D PAGE at the expected pI and MW. All six variable surface lipoproteins encoded in the M. agalactiae PG2T genome were also detected, some of which (such as VpmaY and VpmaD) with high expression levels, as could be expected considering their relevance in providing variability to the mycoplasmal antigenic mosaic.
Figure 3
Figure 3
2-D PAGE map of M. agalactiae PG2T liposoluble proteins illustrating protein identifications obtained by mass spectrometry. Proteins are indicated by grouping all individual identifications corresponding to the same protein in a series of spots.
2D DIGE of liposoluble proteins among the type strain and two field isolates of M. agalactiae
In order to assess the suitability of 2-D PAGE for comparison of the membrane protein composition, the liposoluble protein profiles of M. agalactiae PG2T and two field isolates were compared by 2D DIGE (Figure (Figure44).
Figure 4
Figure 4
2D DIGE of liposoluble proteins extracted from M. agalactiae PG2T and two field strains. Overlay image: image generated from the superimposition of the signals generated by the three samples. White indicates presence of the protein spot in all three isolates. (more ...)
The images generated upon acquisition of the single color channels enable to evaluate the liposoluble protein profiles separately (Figure 4, A, B, C), while comparison of two protein profiles can be performed upon superimposition of two color signals (Figure 4, D, E, F). In the overlay image, the three proteome 2D maps can be compared. Although many spots are shared among the three profiles (in white), a number of differences in expression can be appreciated. In fact, several spots are present only in one (blue, green, red) or two profiles (purple, yellow, light blue). Many already known antigens (such as P80, P48, P40, and most Vpmas) appear in white, indicating superimposition of the three signals and therefore presence in all three bacterial proteomes. Several differences among the three profiles can be easily observed; for example, the series of spots at 40 kDa corresponding to VpmaY (in purple in the overlay image, Figure Figure4)4) is present only in two cases (PG2T and Bortigali) while the series of spots at 23 kDa (in green) is present only in one case (Nurri). The application of this method to an adequate number of isolates might enable to easily detect constantly expressed proteins that might serve as candidate antigens for development of vaccines and diagnostic tools.
GeLC-MS/MS of M. agalactiae PG2 liposoluble proteins
Although well suited for lipoprotein analysis, the 2-D PAGE/MS strategy presents drawbacks in analysis of transmembrane proteins, such as permeases or other highly hydrophobic proteins. Moreover, these protein classes may undergo selective loss during precipitation/resolubilization steps. In order to increase the membrane protein coverage and minimize selective protein loss, SDS-PAGE and GeLC-MS/MS analysis were performed on the non-precipitated Triton X-114 liposoluble protein fraction. A total of 36 slices were cut from the SDS-PAGE gel lane containing the separated liposoluble proteins (Additional file 5) and subjected to nanoHPLC-nanoESI-Q-TOF-MS/MS identification. Upon application of this method, 194 mycoplasma proteins were identified in total, corresponding to 26% of all M. agalactiae PG2T genes, 38 of which were also identified by 2-D PAGE/MS (for a detailed list of protein identifications, see Additional file 6; Additional file 7 reports a summary table listing all unique protein identifications).
Data analysis and classification
A gene ontology (GO) classification was carried out on proteins identified by 2-D PAGE/MS and GeLC-MS/MS. For the first method, proteins (n = 40) were mostly classified by the GO software as hypothetical lipoproteins (65%), cytoplasmic proteins (22%), ribosomal proteins (8%), and other membrane-located proteins (5%). When identifications obtained by GeLC-MS/MS were also included in the GO analysis (n = 194), 43% of all identifications were assigned to proteins located on the membrane, either lipoproteins (17%) or other membrane proteins (26%), whereas 36% were classified as cytoplasmic, 17% as ribosomal, and 4% of unknown localization (Figure (Figure55).
Figure 5
Figure 5
GO graph of proteins identified by 2-D PAGE-MS and GeLC-MS/MS in the Triton X-114 fraction of M. agalactiae PG2T. Protein identifications are classified according to cellular localization.
All protein identifications were then classified according to function (Figure (Figure6,6, and Additional file 7). As expected, a high proportion of the identified proteins perform membrane transport functions (about 16%), and belong mostly to ABC transporters (13%). Transmembrane proteins, such as permeases, were detected only by means of GeLC-MS/MS. Another highly represented functional process was translation (19%), due to the elevated number of ribosomal proteins identified. Hydrolytic enzymes were also significantly represented (6%), highlighting their crucial role for survival of mycoplasmas. Several other functional classes, such as enzymes involved in amino acid, carbohydrate, lipid, and nucleic acid metabolism, were significantly represented in the M. agalactiae PG2T liposoluble protein fraction. Secretion/export systems accounted for 4% of all identified proteins; these components are in fact crucial for maturation and release of secreted proteins, but also for positioning/exposing lipoproteins on the outer side of the bacterial cell. About 19% of proteins could not be assigned a specific function by manual searches or GO classification.
Figure 6
Figure 6
GO graph of proteins identified by GeLC-MS/MS in the Triton X-114 fraction of M. agalactiae PG2T. Protein identifications are classified according to function
Proteomic data were analyzed in order to investigate presence of liposoluble proteins resulting from expression of horizontally-transferred genes [24]. Among 194 identified proteins, 15 (7.8%) were acquired by HGT from the Mycoplasma mycoides cluster (Additional file 8), while 7 (3.7%) were acquired by HGT from other bacteria (Additional file 9), for a total of 22 proteins, making up to 11.5% of all expressed membrane proteins being derived from putative HGT events.
Gathering proteomic information on prokaryotic membranes is a challenging task, due to difficulties in cell fractionation and to the intrinsic chemical properties of membrane proteins in general. Therefore, both systematic and differential proteomic information on prokaryotic membranes is generally lacking. In this work, we approached the systematic characterization of what is believed to be one of the simplest bacterial pathogen membranes, in an attempt to move a step forward in our understanding of its composition, complexity, and function. In addition to its lower complexity, investigating membrane composition and plasticity in mycoplasmas is of particular interest since surface proteins are subjected to size and phase variation, and information on the extent and level of such variation is crucial in studies targeting identification of common immunogens, evaluation of immunological escape mechanisms, and adaptation of the bacterium to its host. All six variable surface lipoproteins encoded in the PG2T genome [37] were detected by 2-D PAGE, although one of these (VpmaY) was not expressed in a field isolate examined by 2D DIGE. Triplicate experiments showed that the two-dimensional expression pattern of each field isolate is relatively stable under laboratory conditions, and that there is a reproducible differential expression of several protein spots in the field isolates compared to the type strain PG2. Interestingly, these differences are being detected in bacteria which were grown in culture media, where all protein variants should theoretically be expressed [37]. It was already demonstrated that the switching mechanism is so fast that it can be pointed out in a single colony on solid culture [14]. This might suggest that the lack of VpmaY in the isolate Nurri could result from a local genetic mutation. A large-scale study performed on a higher number of field isolates might enable the detection of constantly expressed proteins, which might be useful as targets for the development of vaccines and diagnostic tools for CA.
Mycoplasmas have evolved a parasitic lifestyle, and membrane transporters are consequently very important for uptake of nutrients and growth factors. The genome of M. agalactiae PG2T encodes 18 ABC transporters, but proteins from only 10 of these were identified in this study. We also failed to identify all the components of a complete membrane transporter complex; however, it is possible that expression of all sequences encoded by the transporter gene operon may not necessarily take place at the same time. ABC transporters components encoded by different operons may likely interact to form functional transporters, producing the further advantage of creating many different combinations that can help evasion of host defense mechanisms. For instance, the genome of M. agalactiae PG2T encodes for two oligopeptide (Opp) ABC transporters, one typical of the hominis group and one probably transferred by means of horizontal gene transfer mechanisms from M. mycoides subsp. mycoides and M. capricolum subsp. capricolum. We identified the substrate binding protein (OppA) from one operon, and the permease (OppC) and the ATP-binding protein (OppF) from another operon; notably, these proteins create a functional transporter. Moreover, OppA could be more than a simple substrate binding protein, since it was demonstrated to play an important role in pathogenicity in M. hominis by inducing ATP release and cell death of HeLa cells in vitro and by mediating adhesion to host cells [38-40]. Other authors reported a different pattern of expression of these operons: in the study by Nouvel and co-workers [37], only OppA, OppF, and OppD were detected. These apparently controversial results could be due to technical issues, or be dependent on variations in expression of Opps within the PG2T strain. This will need to be elucidated in future studies.
Upon analysis of all MS data, the proteins putatively assigned by the GO software as cytoplasmic accounted to 36%. Among these, many hydrolases were present. However, lipases, peptidases, and nucleases might be associated to the membrane compartment and assist in reducing macromolecules to simple components, enabling their uptake. In fact, mycoplasmas lack many biosynthetic pathways and rely on internalization of nucleotides, amino acids, sugars and lipids from their external environment. Recently, it was reported that hydrolytic enzymes are surface-located in mycoplasmas, and that they can be associated with ABC transporters in order to digest macromolecules before uptake of simpler components, or play major roles in pathogenicity [41]. Interestingly, in the M. agalactiae genome, the genes coding for many of these hydrolases are also located close to ABC transporter operons.
Several other proteins have a predicted cytoplasmic localization, but could be membrane-associated in mycoplasmas, such as the elongation factor tu (EF-Tu) and the E1 beta subunit of the pyruvate dehydrogenase complex. Traditionally, these are considered to be cytoplasmic proteins involved in protein synthesis and energy production, respectively, but it was demonstrated that in M. pneumoniae they are surface exposed and interact with host fibronectin, mediating adhesion [42,43]. It was also demonstrated that many "cytoplasmic" proteins such as the EF-Tu are strong antigens in many mycoplasma species [22,44,45].
Ribosomal proteins represent a significant proportion of the mycoplasma liposoluble proteome. This might appear inconsistent, but in spite of their traditionally cytoplasmic localization, it was already demonstrated that ribosomes interact with the bacterial protein export complex [46]. Moreover, it is well known that in eukaryotes ribosomes are associated with endoplasmic reticulum, where they participate in the protein secretion pathway [47]. Several proteins that take part in other metabolic pathways were also identified in the liposoluble fraction of M. agalactiae PG2T. We could speculate that many proteins involved in nutrient metabolism might associate with proteins devoted to internalization of precursors in metabolizing complexes, and be co-purified with these. Nonetheless, a pre-fractionation of membranes was not performed because of inherent technical difficulties, and we cannot rule out that enzymes with high hydrophobicity might be present as cytoplasmic contaminants.
The recent work by Sirand-Pugnet and coworkers revealed the occurrence of horizontal gene transfer (HGT) events in M. agalactiae. The expression of proteins acquired by HGT highlights the importance of horizontal gene flow for the evolutionary plasticity of mycoplasmas; for instance, by allowing changes in host and/or tissue tropism through acquisition of traits enabling colonization and survival in new niches [24,48]. In total, an impressing 11.7% of proteins expressed on the M. agalactiae membrane are coming from other bacteria, reinforcing the view that an important part in the evolution of mycoplasmas might be driven by genetic exchange with bacteria sharing the same host districts, probably in order to compensate the concurrent process of gene loss [24]. Another interesting observation was the detection of MAG_2340, a hypothetical lipoprotein which is apparently the result of an horizontal gene transfer event with mycoplasmas of the mycoides cluster (Additional file 8), which was not detected by Nouvel et al. in the PG2T liposoluble proteome [37].
Hypothetical proteins were of particular interest; since these did not have an assigned function, similarity searches were conducted with BLAST tools in order to infer their possible role in the biology of mycoplasmas. Among these, the hypothetical lipoprotein MAG_1670 belongs to the mycoides cluster LppA/P72 family, and it is an antigen recognized early and persistently in infection [49]. The hypothetical protein MAG_0250 has an indigoidine synthase A (IdgA)-like domain similar to Clostridium spp. IdgA is involved in the biosynthesis of indigoidine, a blue pigment synthesized by Erwinia chrysanthemi and implicated in pathogenicity and protection from oxidative stress by scavenging oxygen radicals [50]. Indigoidine production increases tolerance to oxidative stress and contributes to aggressiveness, and might therefore act as a virulence factor.
2-D PAGE studies might be extremely powerful for comparison of protein expression in different mycoplasma isolates, especially when considering that lipoproteins can be selectively detected with this method, and that size and phase variations can be easily spotted through the application of powerful differential comparison approaches as the 2D DIGE. However, these need to be integrated with traditional Western immunoblotting and GeLC-MS/MS for a deeper coverage and characterization of other mycoplasmal surface immunogens to be used as tools for vaccination, diagnosis, and therapy. This combined approach allowed the identification and characterization of 194 M. agalactiae proteins putatively localized on the membrane or associated to it, providing useful insights on its composition. In the future, alternative approaches such as blue native electrophoresis and chemical crosslinking of surface proteins will also enable to elucidate functional and structural aspects of membrane proteins that cannot be accounted for by the traditional gel-based proteomic approaches.
Bacterial strains and culture conditions
At least three replicate cultures of Mycoplasma agalactiae PG2T and two Sardinian field isolates (named Bortigali and Nurri), were grown in PPLO medium supplemented with 20% heat inactivated horse serum and 500 μg/mL ampicillin, at 37°C with constant agitation. Mycoplasmas were collected by centrifugation (10 min at 10,000 × g at 4°C), and washed three times with PBS. At least three mycoplasma pellets were obtained from each bacterial culture replicate, and used for genetic and proteomic analyses. Total DNA was extracted from a set of pellets with DNeasy Blood & Tissue Kit (Qiagen), and subjected to FS1-FS2 PCR for species confirmation [51].
Total protein extracts and Triton X-114 fractionation
For total protein extracts, bacterial pellets were resuspended in 1% hot SDS, incubated for 3 minutes at 95°C, chilled, and diluted with lysis buffer (7 M urea, 2 M thiourea, 2.5% CHAPS, 2% ASB-14, 40 mM Tris-HCl pH 8.8, 1% IPG-buffer, protease inhibitors), and insoluble materials were discarded by centrifugation (10 min at 10,000 × g at 4°C) [52]. Hydrophilic and hydrophobic protein fractions were obtained by Triton X-114 fractionation [29,30] and ProteoPrep® Membrane Extraction Kit (Sigma-Aldrich). Proteins samples were quantified as described [52].
SDS-PAGE and 2-D PAGE
SDS-PAGE was performed on 8% polyacrylamide gels on a Protean Tetra Cell (Bio-Rad) following the manufacturer instructions, and gels were stained with PageBlue™ Protein Staining Solution (Fermentas).
Prior to 2-D PAGE, Triton X-114 fractions were precipitated with methanol-chloroform [35] and resuspended in lysis buffer (8 M urea, 2 M thiourea, 2.5% CHAPS, 2% ASB-14, 40 mM Tris-HCl pH 8.8, 1% IPG-buffer, protease inhibitors). Resuspended proteins (150 μg) were then absorbed overnight into 18 cm IPG strips (GE Healthcare, pH 3-10 NL, pH 7-11, and pH 4-7). Strips were focused on an IPGphor (GE Healthcare) for a total of 60,000 Vh. After focusing, strips were equilibrated in 50 mM Tris-HCl, pH 6.8, 2% SDS, 7 M urea, 10% glycerol, supplemented with 2% DTT for 15 min, and then with 2.5% iodoacetamide for 15 min. The second dimension (SDS-PAGE) was conducted on 10% to 18% polyacrylamide gradient gels, on an Ettan DALTsix electrophoresis system (GE Healthcare), following manufacturer's instructions. 2-D gels were silver stained with a mass-compatible method [53] and images were digitalized with an Image Scanner (GE Healthcare).
2D DIGE
For 2D DIGE analysis, the two field isolates Bortigali and Nurri were compared to PG2T. Triton X-114 Protein extracts were precipitated and resuspended in lysis buffer as described above. Then, samples were labeled with CyDye DIGE Fluors (GE Healthcare) according to the minimal labeling protocol provided by the manufacturer. Briefly, after CyDye reconstitution with dimethylformamide (DMF) and preparation of a working solution (200 pmol/μL), 1 μL of diluted CyDye was added to a volume of protein sample equivalent to 50 μg. Samples were left on ice for 30 minutes in the dark, and then 1 μL of 10 mM lysine was added to stop the reaction. Labeled samples were mixed, IPG buffer corresponding to the desired pH range was added at a 1% final concentration, and DeStreak Rehydration Solution (GE Healthcare) was added to a total volume of 340 μL. 18 cm IPG strips (GE Healthcare) were passively rehydrated for at least 6 hours. IEF was carried out on an Ettan IPGphor II (GE Healthcare) for a total of ~60,000 Vh. After focusing, strips were equilibrated in 50 mM Tris-HCl, pH 6.8, 2% SDS, 7 M urea, 10% glycerol, supplemented with 2% DTT for 10 min, and then with 2.5% iodoacetamide for 10 min. Proteins were then subjected to SDS-PAGE in 10-18% gradient polyacrylamide gels on the Ettan DALTsix system (GE Healthcare), following the manufacturer instructions. DIGE images were detected with a Typhoon Scanner (GE Healthcare) and processed with DeCyder (GE Healthcare) for image analysis.
Western Immunoblotting
SDS-PAGE resolved proteins were transferred onto nitrocellulose membranes with a Mini-Trans-Blot Cell (Bio-Rad) at 250 mA for one hour. After blotting, membranes were blocked with PBS-0.05% Tween 20 (PBS-T) containing 3% BSA. Membranes were incubated for one hour with a rabbit hyperimmune serum raised against M. agalactiae recombinant P48 (M. agalactiae rP48) [12]. Membranes were washed five times with PBS-T and incubated with the appropriate HRP-conjugated secondary antibodies (Sigma). After five washes, membranes were developed with SuperSignal West Pico Chemiluminescent Substrate (Pierce) and images were acquired with a VersaDoc MP 4000 Imaging System (Bio-Rad).
Spot picking and in situ tryptic digestion
Protein spots obtained upon 2-D PAGE separation of the Triton X-114 extract from the strain PG2T were manually excised from gels, destained with 15 mM K3Fe(CN)6 in 50 mM Na2S2O3 and stored in acetonitrile. Spots were then subjected to an O/N tryptic digestion at 37°C in 50 mM (NH4)HCO3, pH 8.0, using 40 to 80 ng of trypsin depending on spot intensity. Peptide mixtures were collected by elution with acetonitrile followed by centrifugation. Peptides were then acidified with TFA 20%, dried in SpeedVac®, resuspended in 0.2% formic acid and stored at -20°C.
GeLC-MS/MS
The Triton X-114 fraction was diluted with 4× Laemmli buffer [54], 20 μg of proteins were loaded in an 8% polyacrylamide gel, and SDS-PAGE was performed as previously described. After gel staining, bands were manually excised, destained, reduced, alkylated, and finally subjected to in situ tryptic digestion as previously described [55]. Peptide mixtures were identified by nanoHPLC-nanoESI-Q-TOF-analysis. One-dimensional patterns were analyzed with Quantity One software (Bio-Rad).
MALDI-MS
Mass spectra were recorded on a MALDI micro (Waters, Manchester, UK) equipped with a reflectron analyzer and used in delayed extraction mode, as described previously [56]. Peptide samples were mixed with an equal volume of α-cyano-4-hydroxycynnamic acid as matrix (10 mg/mL in acetonitrile/0.2% TFA) (70:30, v/v), applied to the metallic sample plate, and air dried. Mass calibration was performed by using the standard mixture provided by manufacturer. Raw data, reported as monoisotopic masses, were then introduced into the in-house Mascot Peptide Mass Fingerprinting software (Version 2.2, Matrix Science, Boston, MA), and used for protein identification. Search parameters were as follows: fixed modifications carbamidomethyl (C), variable modifications pyro-Glu (N-term Q) and oxidation (M), peptide tolerance 80 ppm, enzyme trypsin, allowing up to 2 missed cleavages.
LC-MS/MS
LC-MS/MS analyses of tryptic digests were performed on a Q-TOF hybrid mass spectrometer equipped with a nano lock Z-spray source, and coupled on-line with a capillary chromatography system CapLC (Waters, Manchester, UK), as described previously [55]. After loading, the peptide mixture was first concentrated and washed at 20 μL/min onto a reverse-phase pre-column (Symmetry 300, C18, 5 μm, NanoEase, Waters) using 0.2% formic acid as eluent. The sample was then fractionated onto a C18 reverse-phase capillary column (Nanoflow column 5 μm Biosphere C18, 75 μm × 200 mm, Nanoseparations) at a flow rate of 250 nL/min, using a linear gradient of eluent B (0.2% formic acid in 95% acetonitrile) in A (0.2% formic acid in 5% acetonitrile) from 2 to 40% in 27 min. The mass spectrometer was set up in a data-dependent MS/MS mode where a full scan spectrum (m/z acquisition range from 400 to 1600 Da/e) was followed by tandem mass spectra (m/z acquisition range from 100 to 2000 Da/e). Peptide ions were selected as the three most intense peaks of the previous scan. A suitable collision energy was applied depending on the mass and charge of the precursor ion. Argon was used as the collision gas. Mass calibration was conducted on the Glu-fibrino peptide B (Sigma) fragmentation pattern. ProteinLynx software (Version 2.2.5), provided by the manufacturers, was used to analyze raw MS and MS/MS spectra and to generate a peak list which was introduced in the in-house Mascot MS/MS ion search software (Version 2.2, Matrix Science, Boston, MA) for protein identification. NCBI was used as sequence database. Search parameters were as follows: fixed modifications carbamidomethyl (C), variable modifications pyro-Glu (N-term Q) and oxidation (M), peptide tolerance 30 ppm, MS/MS tolerance 0.3 Da, charge state +2 and +3, enzyme trypsin, allowing up to 1 missed cleavage.
Data analysis
MS data were subjected to gene ontology analysis with Blast2GO, using default parameters [57]. Identified proteins were divided into classes for functional and localization analysis; data produced by the software were used for generation of graphs by Microsoft Excel.
Authors' contributions
CC and MFA performed the experimental design, carried out the protein fractionation and electrophoresis, performed data analysis, and drafted the manuscript. DP carried out the mass spectrometry identifications. BC participated in the design of the study. EC and LC performed animal diagnosis, collection of animal samples, isolation, molecular identification, and cultivation of mycoplasmas. SU contributed to coordination of the study and data interpretation, and helped to draft the manuscript. AA and MP conceived the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.
Additional file 1
2-D PAGE map of liposoluble proteins from M. agalactiae PG2T illustrating the protein identifications obtained by MS on the 3-10NL pI Interval.
Additional file 2
2-D PAGE map of liposoluble proteins from M. agalactiae PG2T illustrating the protein identifications obtained by MS on the 7-11 pI Interval.
Additional file 3
2-D PAGE map of liposoluble proteins from M. agalactiae PG2T illustrating the protein identifications obtained by MS on the 4-7 pI Interval.
Additional file 4
Table listing all protein identifications obtained from 2-D PAGE maps. The proteins listed in this table were identified from 2-D PAGE maps of the M. agalactiae PG2T Triton X-114 fraction. Maps are represented in Additional files 1 (pH 3-10NL), 2 (pH 7-11) and 3 (pH 4-7).
Additional file 5
Protein profile of liposoluble proteins before and after precipitation. Right: approach used for GeLC-MS/MS characterization. The bars indicate the regions cut from the PAGE gel and subjected to mass spectrometry characterization. Protein identifications are reported in additional file 6, from top to bottom.
Additional file 6
Table listing all protein identifications obtained by GeLC-MS/MS of the M. agalactiae PG2T Triton X-114 liposoluble fraction. The protein profile used and the number of slices are reported in Additional file 5.
Additional file 7
Functional analysis, number of peptide hits, and method of detection of M. agalactiae PG2T liposoluble proteins. The results of 2D DIGE with the two field strains Nurri and Bortigali are also reported (TPH, total peptide hits; NA, not applicable).
Additional file 8
Proteins identified in the M. agalactiae proteome potentially resulting from Horizontal Gene Transfer events with M. mycoides subsp. mycoides and M. capricolum subsp. capricolum.
Additional file 9
Proteins identified in the M. agalactiae proteome potentially resulting from Horizontal Gene Transfer events with other bacteria.
Acknowledgements
We thank Prof. Christine Citti for kindly providing the type strain PG2T, Dr. Mario Ferrer-Navarro for his helpful suggestions during optimization of the protein fractionation approach, Dr. Vittorio Tedde and Dr. Alessandro Tanca for assistance during electrophoresis and MALDI-MS identification, and Dr. Stefania Ghisaura from Biosistema Scarl for the DIGE experiments. This work was supported by funding from the Grant "Ricerca Sanitaria Finalizzata, Anno 2007, UPB S02.04.010, Cap SC02.1106", and Misura P5 Biodiversità animale (Regione Sardegna).
  • Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Mol Biol Rev. 1998;62:1094–1156. [PMC free article] [PubMed]
  • Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev. 2003;83:417–432. [PubMed]
  • You XX, Zeng YH, Wu YM. Interactions between mycoplasma lipid-associated membrane proteins and the host cells. J Zhejiang Univ Sci B. 2006;7:342–350. doi: 10.1631/jzus.2006.B0342. [PMC free article] [PubMed] [Cross Ref]
  • Kühner S, van Noort V, Betts MJ, Leo-Macias A, Batisse C, Rode M, Yamada T, Maier T, Bader S, Beltran-Alvarez P, Castaño-Diez D, Chen WH, Devos D, Güell M, Norambuena T, Racke I, Rybin V, Schmidt A, Yus E, Aebersold R, Herrmann R, Böttcher B, Frangakis AS, Russell RB, Serrano L, Bork P, Gavin AC. Proteome organization in a genome-reduced bacterium. Science. 2009;27:1235–1240. doi: 10.1126/science.1176343. [PubMed] [Cross Ref]
  • Lambert M. Contagious agalactia of sheep and goats. Rev Sci Tech OIE. 1987;6:699–711. Mycoplasmoses of ruminants.
  • Corrales JC, Esnal A, De la Fe C, Sánchez A, Assunçao P, Poveda JB, Contreras A. Contagious agalactia in small ruminants. Small Rum Res. 2007;68:154–166. doi: 10.1016/j.smallrumres.2006.09.010. [Cross Ref]
  • Bergonier D, Berthelot X, Poumarat F. Contagious agalactia of small ruminants: current knowledge concerning epidemiology, diagnosis and control. Rev Sci Tech Off Int Epizoot. 1997;16:848–873. [PubMed]
  • Chessa B, Pittau M, Puricelli M, Zobba R, Coradduzza E, Dall'ara P, Rosati S, Poli G, Alberti A. Genetic immunization with the immunodominant antigen P48 of Mycoplasma agalactiae stimulates a mixed adaptive immune response in BALBc mice. Res Vet Sci. 2009;86:414–420. doi: 10.1016/j.rvsc.2008.09.010. [PubMed] [Cross Ref]
  • Fusco M, Corona L, Onni T, Marras E, Longheu C, Idini G, Tola S. Development of a sensitive and specific enzyme-linked immunoadsorbent assay based on recombinant antigens for rapid detection of antibodies against Mycoplasma agalactiae in sheep. Clin Vaccine Immunol. 2007;14:420–425. doi: 10.1128/CVI.00439-06. [PMC free article] [PubMed] [Cross Ref]
  • Greco G, Corrente M, Buonavoglia D, Aliberti A, Fasanella A. Inactivated vaccine induces protection against Mycoplasma agalactiae infection in sheep. New Microbiol. 2002;25:17–20. [PubMed]
  • Nicholas RAJ. In: The Merck Veterinary Manual. 9. Kahn CM, Line S, editor. Merck & Co. Inc., Whitehouse Station, NJ; 2005. Contagious agalactia and other mycoplasmal mastitides of small ruminants; pp. 1114–1116.
  • Rosati S, Robino P, Fadda M, Pozzi S, Mannelli A, Pittau M. Expression and antigenic characterization of recombinant Mycoplasma agalactiae P48 major surface protein. Vet Microbiol. 2000;71:201–210. doi: 10.1016/S0378-1135(99)00164-9. [PubMed] [Cross Ref]
  • Tola S, Manunta D, Rocca S, Rocchigiani AM, Idini G, Angioi PP, Leori G. Experimental vaccination against Mycoplasma agalactiae using different inactivated vaccines. Vaccine. 1999;10:2764–2768. doi: 10.1016/S0264-410X(99)00070-5. [PubMed] [Cross Ref]
  • Chopra-Dewasthaly R, Citti C, Glew MD, Zimmermann M, Rosengarten R, Jechlinger W. Phase-locked mutants of Mycoplasma agalactiae: defining the molecular switch of high-frequency Vpma antigenic variation. Mol Microbiol. 2008;67:1196–1210. doi: 10.1111/j.1365-2958.2007.06103.x. [PMC free article] [PubMed] [Cross Ref]
  • McAuliffe L, Kokotovich B, Ayling RD, Nicholas RA. Molecular epidemiological analysis of Mycoplasma bovis isolates from the United Kingdom shows two genetically distinct clusters. J Clin Microbiol. 2004;42:4556–4565. doi: 10.1128/JCM.42.10.4556-4565.2004. [PMC free article] [PubMed] [Cross Ref]
  • Citti C, Watson-McKown R, Droesse M, Wise KS. Gene families encoding phase- and size-variable surface lipoproteins of Mycoplasma hyorhinis. J Bacteriol. 2000;182:1356–1363. doi: 10.1128/JB.182.5.1356-1363.2000. [PMC free article] [PubMed] [Cross Ref]
  • Glew MD, Papazisi L, Poumarat F, Bergonier D, Rosengarten R, Citti C. Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae. Infect Immun. 2000;68:4539–4548. doi: 10.1128/IAI.68.8.4539-4548.2000. [PMC free article] [PubMed] [Cross Ref]
  • Fleury B, Bergonier D, Berthelot X, Peterhans E, Frey J, Vilei EM. Characterization of P40, a cytadhesin of Mycoplasma agalactiae. Infect Immun. 2002;70:5612–5621. doi: 10.1128/IAI.70.10.5612-5621.2002. [PMC free article] [PubMed] [Cross Ref]
  • Fleury B, Bergonier D, Berthelot X, Schlatter Y, Frey J, Vilei EM. Characterization and analysis of a stable serotype-associated membrane protein (P30) of Mycoplasma agalactiae. J Clin Microbiol. 2001;39:2814–2822. doi: 10.1128/JCM.39.8.2814-2822.2001. [PMC free article] [PubMed] [Cross Ref]
  • Rosati S, Pozzi S, Robino P, Montinaro B, Conti A, Fadda M, Pittau M. P48 major surface antigen of Mycoplasma agalactiae is homologous to a malp product of Mycoplasma fermentans and belongs to a selected family of bacterial lipoproteins. Infect Immun. 1999;67:6213–6216. [PMC free article] [PubMed]
  • Tola S, Crobeddu S, Chessa G, Uzzau S, Idini G, Ibba B, Rocca S. Sequence, cloning, expression and characterisation of the 81-kDa surface membrane protein (P80) of Mycoplasma agalactiae. FEMS Microbiol Lett. 2001;202:45–50. doi: 10.1111/j.1574-6968.2001.tb10778.x. [PubMed] [Cross Ref]
  • Jores J, Meens J, Buettner FF, Linz B, Naessens J, Gerlach GF. Analysis of the immunoproteome of Mycoplasma mycoides subsp. mycoides small colony type reveals immunogenic homologues to other known virulence traits in related Mycoplasma species. Vet Immunol Immunopathol. 2009;131:238–245. doi: 10.1016/j.vetimm.2009.04.016. [PubMed] [Cross Ref]
  • Minion FC. Mycoplasma gene expression in Escherichia coli. Methods Mol Biol. 1998;104:259–265. [PubMed]
  • Sirand-Pugnet P, Lartigue C, Marenda M, Jacob D, Barré A, Barbe V, Schenowitz C, Mangenot S, Couloux A, Segurens B, de Daruvar A, Blanchard A, Citti C. Being pathogenic, plastic, and sexual while living with a nearly minimal bacterial genome. PLoS Genet. 2007;3:e75. doi: 10.1371/journal.pgen.0030075. [PubMed] [Cross Ref]
  • Görg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics. 2004;4:3665–3685. doi: 10.1002/pmic.200401031. [PubMed] [Cross Ref]
  • Razin S. Peculiar properties of mycoplasmas: The smallest self-replicating prokaryotes. FEMS Microbiol Lett. 1992;15:423–431. [PubMed]
  • Regula JT, Ueberle B, Boguth G, Görg A, Schnölzer M, Herrmann R, Frank R. Towards a two-dimensional proteome map of Mycoplasma pneumoniae. Electrophoresis. 2000;21:3765–3780. doi: 10.1002/1522-2683(200011)21:17<3765::AID-ELPS3765>3.0.CO;2-6. [PubMed] [Cross Ref]
  • Wasinger VC, Pollack JD, Humphery-Smith I. The proteome of Mycoplasma genitalium. Chaps-soluble component. Eur J Biochem. 2000;267:1571–1582. doi: 10.1046/j.1432-1327.2000.01183.x. [PubMed] [Cross Ref]
  • Bordier C. Phase-separation of integral membrane proteins in Triton X-114 solution. J Biol Chem. 1981;25:1604–1607. [PubMed]
  • Pittau M, Fadda M, Briguglio P. Triton X-114 phase fractionation of Mycoplasma agalactiae membrane proteins and affinity purification of specific antibodies. Atti Soc Ital Sci Vet. 1990;44:925–928.
  • Donoghue PM, Hughes C, Vissers JP, Langridge JI, Dunn MJ. Nonionic detergent phase extraction for the proteomic analysis of heart membrane proteins using label-free LC-MS. Proteomics. 2008;8:3895–3905. doi: 10.1002/pmic.200800116. [PubMed] [Cross Ref]
  • Li YZ, Ho YP, Chen ST, Chiou TW, Li ZS, Shiuan D. Proteomic comparative analysis of pathogenic strain 232 and avirulent strain J of Mycoplasma hyopneumoniae. Biochemistry (Mosc) 2009;74:215–220. doi: 10.1134/S0006297909020138. [PubMed] [Cross Ref]
  • Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem. 2005;382:669–678. doi: 10.1007/s00216-005-3126-3. [PubMed] [Cross Ref]
  • Timms JF, Cramer R. Difference gel electrophoresis. Proteomics. 2008;8:4886–4897. doi: 10.1002/pmic.200800298. [PubMed] [Cross Ref]
  • Ünlü M, Morgan ME, Minden JS. Difference gel electrophoresis: A single method for detecting changes in protein extracts. Electrophoresis. 1997;18:2071–2077. doi: 10.1002/elps.1150181133. [PubMed] [Cross Ref]
  • Schirle M, Heurtier MA, Kuster B. Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics. 2003;2:1297–1305. doi: 10.1074/mcp.M300087-MCP200. [PubMed] [Cross Ref]
  • Nouvel LX, Sirand-Pugnet P, Marenda MS, Sagné E, Barbe V, Mangenot S, Schenowitz C, Jacob D, Barré A, Claverol S, Blanchard A, Citti C. Comparative genomic and proteomic analyses of two Mycoplasma agalactiae strains: clues to the macro- and micro-events that are shaping mycoplasma diversity. BMC Genomics. 2010;2:11–86. [PMC free article] [PubMed]
  • Henrich B, Hopfe M, Kitzerow A, Hadding U. The adherence-associated lipoprotein P100, encoded by an opp operon structure, functions as the oligopeptide-binding domain OppA of a putative oligopeptide transport system in Mycoplasma hominis. J Bacteriol. 1999;181:4873–4878. [PMC free article] [PubMed]
  • Hopfe M, Henrich B. OppA, the substrate-binding subunit of the oligopeptide permease, is the major Ecto-ATPase of Mycoplasma hominis. J Bacteriol. 2004;186:1021–1028. doi: 10.1128/JB.186.4.1021-1028.2004. [PMC free article] [PubMed] [Cross Ref]
  • Hopfe M, Henrich B. OppA, the ecto-ATPase of Mycoplasma hominis induces ATP release and cell death in HeLa cells. BMC Microbiol. 2008;8:55. doi: 10.1186/1471-2180-8-55. [PMC free article] [PubMed] [Cross Ref]
  • Schmidt JA, Browning GF, Markham PF. Mycoplasma hyopneumoniae mhp379 is a Ca2+-dependent, sugar-nonspecific exonuclease exposed on the cell surface. J Bacteriol. 2007;189:3414–3424. doi: 10.1128/JB.01835-06. [PMC free article] [PubMed] [Cross Ref]
  • Balasubramanian S, Kannan TR, Baseman JB. The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin. Infect Immun. 2008;76:3116–3323. doi: 10.1128/IAI.00173-08. [PMC free article] [PubMed] [Cross Ref]
  • Dallo SF, Kannan TR, Blaylock MW, Baseman JB. Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol. 2002;46:1041–1051. doi: 10.1046/j.1365-2958.2002.03207.x. [PubMed] [Cross Ref]
  • Alonso JM, Prieto M, Parra F. Genetic and antigenic characterisation of elongation factor Tu from Mycoplasma mycoides subsp. mycoides SC. Vet Microbiol. 2002;89:277–289. doi: 10.1016/S0378-1135(02)00258-4. [PubMed] [Cross Ref]
  • Bercic RL, Slavec B, Lavric M, Narat M, Bidovec A, Dovc P, Bencina D. Identification of major immunogenic proteins of Mycoplasma synoviae isolates. Vet Microbiol. 2008;127:147–54. doi: 10.1016/j.vetmic.2007.07.020. [PubMed] [Cross Ref]
  • Johnson AE. The structural and functional coupling of two molecular machines, the ribosome and the translocon. J Cell Biol. 2009;185:765–767. doi: 10.1083/jcb.200902014. [PMC free article] [PubMed] [Cross Ref]
  • White SH, von Heijne G. How translocons select transmembrane helices. Annu Rev Biophys. 2008;37:23–42. doi: 10.1146/annurev.biophys.37.032807.125904. [PubMed] [Cross Ref]
  • Marenda M, Barbe V, Gourgues G, Mangenot S, Sagne E, Citti C. A new integrative conjugative element occurs in Mycoplasma agalactiae as chromosomal and free circular forms. J Bacteriol. 2006;188:4137–4141. doi: 10.1128/JB.00114-06. [PMC free article] [PubMed] [Cross Ref]
  • Cheng X, Nicolet J, Miserez R, Kuhnert P, Krampe M, Pilloud T, Abdo EM, Griot C, Frey J. Characterization of the gene for an immunodominant 72 kDa lipoprotein of Mycoplasma mycoides subsp. mycoides small colony type. Microbiology. 1996;142:3515–3524. doi: 10.1099/13500872-142-12-3515. [PubMed] [Cross Ref]
  • Reverchon S, Rouanet C, Expert D, Nasser W. Characterization of Indigoidine Biosynthetic Genes in Erwinia chrysanthemi and Role of This Blue Pigment in Pathogenicity. J Bacteriol. 2002;184:654–665. doi: 10.1128/JB.184.3.654-665.2002. [PMC free article] [PubMed] [Cross Ref]
  • Tola S, Idini G, Manunta D, Galleri G, Angioi A, Rocchigiani AM, Leori G. Rapid and specific detection of Mycoplasma agalactiae by polymerase chain reaction. Vet Microbiol. 1996;51:77–84. doi: 10.1016/0378-1135(96)00023-5. [PubMed] [Cross Ref]
  • Ferrer-Navarro M, Gómez A, Yanes O, Planell R, Avilés FX, Piñol J, Pérez J, Pons A, Querol E. Proteome of the bacterium Mycoplasma penetrans. J Proteome Res. 2006;5:688–694. doi: 10.1021/pr050340p. [PubMed] [Cross Ref]
  • Chevallet M, Luche S, Rabilloud T. Silver staining of proteins in polyacrylamide gels. Nat Protoc. 2006;1:1852–1858. doi: 10.1038/nprot.2006.288. [PMC free article] [PubMed] [Cross Ref]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [PubMed] [Cross Ref]
  • Addis MF, Tanca A, Pagnozzi D, Crobu S, Fanciulli G, Cossu-Rocca P, Uzzau S. Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics. 2009;9:3815–3823. doi: 10.1002/pmic.200800971. [PubMed] [Cross Ref]
  • Addis MF, Tanca A, Pagnozzi D, Rocca S, Uzzau S. 2-D PAGE and MS analysis of proteins from formalin-fixed, paraffin-embedded tissues. Proteomics. 2009;9:4329–4339. doi: 10.1002/pmic.200900010. [PubMed] [Cross Ref]
  • Götz S, García-Gómez JM, Terol J, Williams TD, Nueda MJ, Robles M, Talón M, Dopazo J, Conesa A. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 2008;36:3420–3435. doi: 10.1093/nar/gkn176. [PMC free article] [PubMed] [Cross Ref]
Articles from BMC Microbiology are provided here courtesy of
BioMed Central